1
Investor Presentation
December 2009
BSE Scrip Code : 531335 NSE Scrip Code : ZYDUSWELL
Investor Presentation December 2009 BSE Scrip Code : 531335 NSE - - PowerPoint PPT Presentation
Investor Presentation December 2009 BSE Scrip Code : 531335 NSE Scrip Code : ZYDUSWELL 1 Our Vision We bring Wellness to your Life We will create new experiences by our products that will nourish, nurture and energise your life We shall
1
BSE Scrip Code : 531335 NSE Scrip Code : ZYDUSWELL
2
3
32 40 70
2000 2008 2025
# of Diabetic Patients in India as per WHO Estimates (Millions)
4
5
6
7
8
1539 1947
FY 07-08 FY 08-09
Sales (Rs. Mio.)
190 249 FY 07-08 FY 08-09
Net Profit # (Rs. Mio.)
For better comparison, numbers of consumer business of Cadila Healthcare Ltd. for FY 2007-08 have been included in above numbers # Excludes Exceptional Items
Sugar Free 778 ▲16% EverYuth 501 ▲63% Nutralite 668 ▲19%
27% 31%
(12.8%) (12.3%)
Financial Position as at 31st Mar 09
Net Worth : 690 Net Fixed Assets : 396 Net Current Assets : 301 Cash Balance : 507 # of Equity Shares : 39.07 Mio. Promoters’ holding : 72.25%
9
18.4% 19.9% FY 07-08 FY 08-09
EBIDTA Margins
10
11
Note : H1 08-09 numbers include numbers of Consumer business of Cadila Healthcare Ltd. to make like-to-like comparison.
H1 09-10 H1 08-09 % Gr y-y Income from Operations 1,290 972 32.7% EBIDT 211 152 39.1% EBIDT Margin (% to total opr. income) 16.4% 15.6% 0.8% PBT 205 149 37.7% PBT Margin (% to total opr. income) 15.9% 15.3% 0.6% Net Profit 135 99 37.2% NP Margin (% to total opr. income) 10.5% 10.1% 0.2% EPS Rs. (not annualised) 3.46 2.52 37.2%
12
IR Contact : Vishal Gor, +91 79 268 68 235